Laurie Toich, Assistant Editor

Bill would expand access for seniors to basic services at a local pharmacy.

Senators re-introduce The Pharmacy and Medically Underserved Areas Enhancement Act.

Some Republicans show support for Bernie Sanders’ amendment to legalize the importation of cheaper prescription drugs.

Treatment for rheumatoid arthritis carries numerous difficulties, from physical challenges to gaining access to new drugs.

Adrenaclick is about one-sixth of the cost for the EpiPen.

Semaglutide was not shown to increase cardiovascular risks for patients with diabetes.

New drug process may selectively kill cancer cells quicker than current drugs.

Top news of the day from across the healthcare landscape.

A new process could create cancer drugs from microbes found in soil.

Patients with an abundance of Clostridium Xia clade and Holdemania were cured by an autologous fecal transplant.

Iowa seeks to lower drug costs through engaging in a pharmacy benefit manager restriction law, and an anti-trust lawsuit.

Top trends will include changing policies, pursuing value, and improving access to care.

Metformin plus syrosingopine seen to shrink tumors in mice models of liver cancer.

Top news of the day from across the healthcare landscape.

Calcium channel blockers prevented cancer cells from invading surrounding tissue.

The novel tool will be integrated into the National Cancer Institute’s current risk assessment tool.

Patients who underwent early uterine cancer surgery had up to a 20% increased mortality risk.

The National Cancer Institute Formulary will streamline the process to receive drugs for cancer research.

President-elect Donald Trump took aim at the pharmaceutical industry, causing significant losses in the market for several manufacturers.

Specialty pharmacies concerned that pharmacy benefit managers are directing patients to their own in-house pharmacies.

Pharmaceutical stocks plummet after a yesterday’s press conference for President-elect Donald Trump.

Many specialty pharmacies have filed lawsuits against PBMs alleging the companies are steering customers towards their own pharmacies.

A novel test uses results from a routine blood test to accurately determine cancer survival.

This biosimilar payment model is designed to create a significant financial incentive for physicians to prescribe these drugs.

The FDA has not issued an approval for the drug and it is not indicated to treat any conditions.

PNC-27 may contain Variovorax paradoxus bacteria.

A drug marketed as a potential cure for cancer has not been approved for any indications and may contain harmful bacteria.

Medrad Intego PET Infusion System recalled due to particulate matter in medicine vials.

Source Administration Sets have been recalled due to particulate matter contaminating drugs.

Top news of the day from across the healthcare landscape.